Simplifying Global Compliance
CDRH Explains Itself as Ethicon Prepares to Defend Its Sedasys
Devices & Diagnostics Letter
As Johnson & Johnson (J&J) subsidiary Ethicon Endo-Surgery prepares to defend its computer-assisted personalized sedation system before an independent advisory panel convened by FDA Commissioner Margaret Hamburg, CDRH is finally explaining why it rejected the Sedasys device in the first place.
To View This Article:
Subscribe To Devices & Diagnostics Letter
Devices & Diagnostics Letter Subscription
With a subscription to Devices & Diagnostics Letter (D&DL), you get professionally researched, fully vetted, expertly written articles by our experienced staff for the kind of quick-read weekly update you need to stay current — without having to waste a minute of your busy work day on unproductive internet searches.
BONUS: In every issue, you get links to additional documents that support D&DL’s articles, such as draft and final guidances, warning letters, proposed and final rules, closeout letters, full texts of proposed legislation, GAO reports, and many others.
There’s absolutely no risk to you. You get our 100% Money-Back Guarantee: If at any time, for any reason, you become dissatisfied with Devices & Diagnostics Letter
, you may cancel your subscription and receive a full refund. No questions asked.
So, why wait? Become a subscriber to Devices & Diagnostics Letter today. It couldn’t be easier.
Buy This Article Now
Copyright ©2014. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing